Human demyelinating disease and the polyomavirus JCV.

Area of Science:

• Neuroscience
• Virology
• Immunology

Background:

• Demyelinating diseases, including hereditary leukodystrophies, multiple sclerosis (MS), and progressive multifocal leukoencephalopathy (PML), affect the central and peripheral nervous systems.
• JC virus (JCV), a human neurotropic polyomavirus, is the causative agent of PML, a fatal demyelinating disease.
• JCV infections are typically latent due to immune system control, particularly cell-mediated immunity.

Purpose of the Study:

• To elucidate the role of JC virus (JCV) in the pathogenesis of progressive multifocal leukoencephalopathy (PML).
• To understand the factors contributing to the reactivation of latent JCV infections.
• To highlight the association between immunosuppression and the risk of developing PML.

Main Methods:

• Review of serological studies on JCV prevalence.
• Analysis of the characteristics of JCV, including its viral family and genome structure.
• Examination of the relationship between immune status and JCV replication.

Main Results:

• JCV is widespread in the human population but usually remains latent.
• Severe immunosuppression is a significant risk factor for JCV replication and the development of PML.
• PML primarily affects immunosuppressed individuals, particularly those with HIV/AIDS.

Conclusions:

• JC virus (JCV) is the etiological agent of progressive multifocal leukoencephalopathy (PML).
• Maintaining robust cell-mediated immunity is crucial for controlling JCV infections.
• Immunosuppressed states create a risk for JCV reactivation and subsequent PML development.